Product Name :
Anti-SELP/CD62(Crizanlizumab Biosimilar) Antibody
Applications:
ELISA,Flow Cyt
Reactivity :
Human SELP/CD62
Conjugate:
Unconjugated
Advantages :
High lot-to-lot consistencyIncreased sensitivity and higher affinityAnimal-free production
Description:
| Description: Anti-SELP/CD62(Crizanlizumab Biosimilar) Antibody is a biosimilar antibody directed against Human SELP/CD62. | Isotype: Human IgG2 | Conjugate: Unconjugated | Specificity: Human SELP/CD62 | Clonality: Monoclonal | Purity: Recombinant Expression and Affinity purified | Concentration: 1mg/ml | Formation: Liquid, 10mM PBS (pH 7.5) | Storage: Store at –20 °C, (Avoid freeze/thaw cycles)
Description2 :
Anti-SELP/CD62(Crizanlizumab Biosimilar) Antibody is a biosimilar antibody directed against Human SELP/CD62.{{2444815-84-1} web|{2444815-84-1} Purity & Documentation|{2444815-84-1} Purity|{2444815-84-1} custom synthesis}
Immunogen:
Host :
Isotype:
Human IgG2
Purity :
Recombinant Expression and Affinity purified
Buffer :
Storage :
Function:
ELISA: 1:5000-1:20000Flow Cyt: 1:200-1:1000Other tested applications.{{1313725-88-0} medchemexpress|{1313725-88-0} Protocol|{1313725-88-0} Purity|{1313725-88-0} supplier} Dilution factors are presented in the form of a range because the optimal dilution is a function of many factors, such as antigen density, permeability, etc.PMID:31082099 The actual dilution used must be determined empirically.